SKN | Exact Sciences Corporation Plans $1 Billion Follow-On Offering to Accelerate Cancer Screening and Diagnostics Expansion
Exact Sciences Corporation (EXAS), a global leader in cancer detection and diagnostics, has announced plans for a $1 billion follow-on public offering to strengthen...
SKN | Christian Tech Platform Gloo Holdings Prices IPO at $8, Below the Range
Gloo Holdings, a Christian-focused digital platform, has priced its initial public offering at $8 per share, below the previously indicated range of $9–$11. The...
SKN | Nuvation Bio Inc. Advances Toward $140 Million IPO to Accelerate Pipeline of Targeted Oncology Therapies
Nuvation Bio Inc., a clinical-stage biotechnology company developing next-generation cancer therapies, is preparing a $140 million initial public offering (IPO) to advance its portfolio...
SKN | Terns Pharmaceuticals, Inc. Prepares $150 Million IPO to Advance Obesity and Oncology Drug Pipeline
Terns Pharmaceuticals, Inc., a rapidly emerging clinical-stage biotechnology company focused on developing small-molecule therapies for obesity and oncology, is preparing a $150 million initial...
SKN | Jazz Pharmaceuticals plc Targets $300 Million IPO Expansion to Strengthen Sleep, Oncology, and Rare Disease Portfolio
Jazz Pharmaceuticals plc, a global biopharmaceutical company specializing in sleep medicine, oncology, and rare neurological disorders, is preparing a $300 million initial public offering...
